Analyst Ranking
Bottom 22%
#3852 out of 4871 analysts
Average Return
-0.26%
Win Rate
46%16 out of 35
Risk vs Reward
Poor
Good

Timothy Daley's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Stevanato Group SpaSTVN
+72.82%$18.10$31.28
2022-08-14 -
2023-08-14
Strong Buy
Stevanato Group SpaSTVN
+57.79%$16.94$26.73
2022-04-24 -
2023-04-24
Strong Buy
Stevanato Group SpaSTVN
+52.61%$15.68$23.93
2022-03-08 -
2023-03-08
Strong Buy
Danaher CorpDHR
+26.99%$215.70$273.91
2023-10-02 -
2024-10-02
Strong Buy
Stevanato Group SpaSTVN
+26.18%$23.26$29.35
2023-03-08 -
2024-03-08
Strong Buy

Timothy Daley's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Qiagen NvQGEN
1Hold$45.32N/AInitiates Coverage On
a year ago
Myriad Genetics IncMYGN
1Hold$20.00N/AInitiates Coverage On
a year ago
Revvity IncRVTY
1Hold$95.00N/AInitiates Coverage On
a year ago
Bruker CorpBRKR
1Hold$72.00N/AInitiates Coverage On
a year ago
Agilent Technologies IncA
5Strong Buy$145.00N/AMaintains
a year ago
Mettler Toledo International IncMTD
5Strong Buy$1,300.00N/AMaintains
a year ago
Waters CorpWAT
5Hold$285.00N/AMaintains
a year ago
Danaher CorpDHR
3Strong Buy$247.00N/AMaintains
2 years ago
Charles River Laboratories International IncCRL
4Strong Buy$275.00N/AMaintains
2 years ago
Labcorp Holdings IncLH
3Strong Buy$270.00N/AMaintains
2 years ago
Neogen CorpNEOG
2Strong Buy$28.00N/AMaintains
2 years ago
Stevanato Group SpaSTVN
6Strong Buy$35.00N/AMaintains
2 years ago
Thermo Fisher Scientific IncTMO
3Strong Sell$520.00N/AMaintains
2 years ago
Inotiv IncNOTV
1Strong Buy$9.00N/AInitiates Coverage On
2 years ago
Repligen CorpRGEN
1Strong Buy$185.00N/AInitiates Coverage On
2 years ago
Hologic IncHOLX
3Hold$85.00N/AMaintains
2 years ago
Iqvia Holdings IncIQV
2Hold$220.00N/AMaintains
2 years ago
Icon PLCICLR
2Hold$220.00N/AMaintains
2 years ago
Avantor IncAVTR
4Strong Buy$28.00N/AMaintains
2 years ago
Quest Diagnostics IncDGX
2Hold$140.00N/AMaintains
2 years ago
Bio Techne CorpTECH
3Hold$90.00N/AUpgrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.